Literature DB >> 8856360

Chemokines: a superfamily of chemotactic cytokines.

S Sozzani1, M Locati, P Allavena, J Van Damme, A Mantovani.   

Abstract

Chemokines are a bipartite family of chemotactic proteins that bear the structural hallmark of four cysteine residues, the first two of which are in tandem. The spectrum of action of chemokines encompasses a large number of leukocyte populations, including monocytes, granulocytes, lymphocytes, NK and dendritic cells. Although the spectrum of action of chemokines largely overlaps, clear differences are still present. Chemokines play an important role in the recruitment of leukocytes at the site of inflammation, allergic reaction and tumors. Available information on receptor usage by MCP-1 and related chemokines and signal transduction pathways is reviewed. The better understanding of signaling mechanisms will provide a new basis for the development of therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856360     DOI: 10.1007/bf02592349

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  16 in total

1.  Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.

Authors:  O Fahy; H Porte; S Sénéchal; H Vorng; A R McEuen; M G Buckley; A F Walls; B Wallaert; A B Tonnel; A Tsicopoulos
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Anti-inflammatory effect of linear polarized infrared irradiation on interleukin-1beta-induced chemokine production in MH7A rheumatoid synovial cells.

Authors:  Yasuko Shibata; Naomi Ogura; Keisuke Yamashiro; Shogo Takashiba; Toshirou Kondoh; Keiji Miyazawa; Masaru Matsui; Yoshimitsu Abiko
Journal:  Lasers Med Sci       Date:  2005-07-27       Impact factor: 3.161

3.  CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis.

Authors:  A-L Feng; J-K Zhu; J-T Sun; M-X Yang; M R Neckenig; X-W Wang; Q-Q Shao; B-F Song; Q-F Yang; B-H Kong; X Qu
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

Review 4.  Chemokines in multiple myeloma.

Authors:  Rohit Aggarwal; Irene M Ghobrial; G David Roodman
Journal:  Exp Hematol       Date:  2006-10       Impact factor: 3.084

5.  Redox regulation of chemokine receptor expression.

Authors:  A Saccani; S Saccani; S Orlando; M Sironi; S Bernasconi; P Ghezzi; A Mantovani; A Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

6.  Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation.

Authors:  Chien-Chi Lin; Patrick D Boyer; Alex A Aimetti; Kristi S Anseth
Journal:  J Control Release       Date:  2009-11-29       Impact factor: 9.776

7.  SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus.

Authors:  Silke Heinisch; Lynn G Kirby
Journal:  Neuropharmacology       Date:  2009-09-13       Impact factor: 5.250

8.  Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.

Authors:  Weidong Zhang; Zhuang Chen; Fang Li; Huse Kamencic; Bernie Juurlink; John R Gordon; Jim Xiang
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

9.  Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination.

Authors:  J P Buschmann; K Berger; H Awad; T Clarner; C Beyer; M Kipp
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

10.  RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.

Authors:  Marina Stolina; Georg Schett; Denise Dwyer; Steven Vonderfecht; Scot Middleton; Diane Duryea; Efrain Pacheco; Gwyneth Van; Brad Bolon; Ulrich Feige; Debra Zack; Paul Kostenuik
Journal:  Arthritis Res Ther       Date:  2009-12-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.